Sign in

CIK 0001806952 · Non-accelerated filer<br>Smaller reporting company

Lyell Immunopharma, Inc.

Sign in to watch
Ticker
LYEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
833006753
Phone
650 695-0677
Business address
201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  9. 8-K Event Delisting notice
  10. 8-K/A Event Exhibits
  11. 8-K Event Other events
  12. 424B5 Offering Prospectus
  13. EFFECT Other Notice of Effectiveness
  14. CORRESP Other Correspondence Between Filers and SEC Staff
  15. UPLOAD Other SEC-generated Letter
  16. S-3 Offering Registration Statement
  17. 8-K Event Executive or director change
  18. SC 13G/A Stake Amended Statement of Ownership
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations

Page 9 of 19 · 364 filings